Strata Skin Sciences Price to Free Cash Flow Ratio 2011-2025 | SSKN
Historical price to free cash flow ratio values for Strata Skin Sciences (SSKN) since 2011.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Strata Skin Sciences Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-11-13 | 1.52 | 0.00 | |
| 2025-06-30 | 2.29 | $-0.64 | 0.00 |
| 2025-03-31 | 2.64 | $-0.12 | 0.00 |
| 2024-12-31 | 2.91 | $-0.38 | 0.00 |
| 2024-09-30 | 2.75 | $-0.51 | 0.00 |
| 2024-06-30 | 3.07 | $-0.99 | 0.00 |
| 2024-03-31 | 3.78 | $-1.27 | 0.00 |
| 2023-12-31 | 5.50 | $-1.59 | 0.00 |
| 2023-09-30 | 5.95 | $-1.93 | 0.00 |
| 2023-06-30 | 9.50 | $-1.75 | 0.00 |
| 2023-03-31 | 10.59 | $-1.79 | 0.00 |
| 2022-12-31 | 7.90 | $-1.34 | 0.00 |
| 2022-09-30 | 8.71 | $-1.04 | 0.00 |
| 2022-06-30 | 9.61 | $-0.87 | 0.00 |
| 2022-03-31 | 14.70 | $-0.75 | 0.00 |
| 2021-12-31 | 14.65 | $-0.63 | 0.00 |
| 2021-09-30 | 18.40 | $-0.60 | 0.00 |
| 2021-06-30 | 15.60 | $-0.69 | 0.00 |
| 2021-03-31 | 16.70 | $-0.37 | 0.00 |
| 2020-12-31 | 15.00 | $-0.02 | 0.00 |
| 2020-09-30 | 13.50 | $0.41 | 32.67 |
| 2020-06-30 | 11.50 | $0.89 | 12.93 |
| 2020-03-31 | 9.50 | $0.73 | 12.98 |
| 2019-12-31 | 20.80 | $0.66 | 31.46 |
| 2019-09-30 | 21.50 | $1.21 | 17.75 |
| 2019-06-30 | 24.90 | $1.65 | 15.06 |
| 2019-03-31 | 28.50 | $1.46 | 19.55 |
| 2018-12-31 | 26.00 | $1.47 | 17.67 |
| 2018-09-30 | 35.40 | $6.91 | 5.13 |
| 2018-06-30 | 20.50 | $7.62 | 2.69 |
| 2018-03-31 | 11.70 | $11.36 | 1.03 |
| 2017-12-31 | 12.30 | $14.08 | 0.87 |
| 2017-09-30 | 17.70 | $14.23 | 1.24 |
| 2017-06-30 | 24.30 | $14.61 | 1.66 |
| 2017-03-31 | 30.25 | $9.47 | 3.19 |
| 2016-12-31 | 22.00 | $1.39 | 15.82 |
| 2016-09-30 | 26.50 | $-6.89 | 0.00 |
| 2016-06-30 | 30.50 | $-16.83 | 0.00 |
| 2016-03-31 | 47.25 | $-19.97 | 0.00 |
| 2015-12-31 | 55.50 | $-38.69 | 0.00 |
| 2015-09-30 | 57.00 | $-63.46 | 0.00 |
| 2015-06-30 | 57.50 | $-89.88 | 0.00 |
| 2015-03-31 | 128.50 | $-118.22 | 0.00 |
| 2014-12-31 | 60.00 | $-167.03 | 0.00 |
| 2014-09-30 | 86.00 | $-171.20 | 0.00 |
| 2014-06-30 | 160.60 | $-207.28 | 0.00 |
| 2014-03-31 | 311.50 | $-241.27 | 0.00 |
| 2013-12-31 | 320.00 | $-267.06 | 0.00 |
| 2013-09-30 | 365.00 | $-345.22 | 0.00 |
| 2013-06-30 | 465.00 | $-390.54 | 0.00 |
| 2013-03-31 | 580.00 | $-404.14 | 0.00 |
| 2012-12-31 | 895.00 | $-400.01 | 0.00 |
| 2012-09-30 | 1605.00 | $-368.96 | 0.00 |
| 2012-06-30 | 1630.00 | $-330.99 | 0.00 |
| 2012-03-31 | 2240.00 | $-351.25 | 0.00 |
| 2011-12-31 | 1845.00 | $-345.49 | 0.00 |
| 2011-09-30 | 2215.00 | $-389.11 | 0.00 |
| 2011-06-30 | 1170.00 | $-392.08 | 0.00 |
| 2011-03-31 | 1760.00 | $-389.90 | 0.00 |
| 2010-12-31 | 1675.00 | $-412.89 | 0.00 |
| 2010-09-30 | 3260.00 | $-455.52 | 0.00 |
| 2010-06-30 | 3720.00 | $-474.51 | 0.00 |
| 2010-03-31 | 3710.00 | $-484.21 | 0.00 |
| 2009-12-31 | 5155.00 | $-480.82 | 0.00 |
| 2009-09-30 | 4790.00 | $-453.16 | 0.00 |
| 2009-06-30 | 3895.00 | $-454.82 | 0.00 |
| 2009-03-31 | 2175.00 | $-494.38 | 0.00 |
| 2008-12-31 | 1675.00 | $-507.23 | 0.00 |
| 2008-09-30 | 2610.00 | $-476.54 | 0.00 |
| 2008-06-30 | 3830.00 | $-444.87 | 0.00 |
| 2008-03-31 | 2955.00 | $-412.07 | 0.00 |
| 2007-12-31 | 2255.00 | $-397.39 | 0.00 |
| 2007-09-30 | 2750.00 | $-399.91 | 0.00 |
| 2007-06-30 | 3360.00 | $-439.53 | 0.00 |
| 2007-03-31 | 2575.00 | $-454.13 | 0.00 |
| 2006-12-31 | 3600.00 | $-471.48 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.009B | $0.034B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.674B | 59.39 |
| Tempus AI (TEM) | United States | $12.352B | 0.00 |
| Doximity (DOCS) | United States | $9.545B | 39.50 |
| Hims & Hers Health (HIMS) | United States | $8.883B | 72.26 |
| IRhythm Technologies (IRTC) | United States | $5.771B | 0.00 |
| Hinge Health (HNGE) | United States | $3.320B | 0.00 |
| Heartflow (HTFL) | United States | $2.981B | 0.00 |
| Privia Health (PRVA) | United States | $2.979B | 186.31 |
| Inspire Medical Systems (INSP) | United States | $2.642B | 43.71 |
| 10x Genomics (TXG) | United States | $2.078B | 0.00 |
| Enovis (ENOV) | United States | $1.787B | 9.38 |
| Omnicell (OMCL) | United States | $1.654B | 33.82 |
| Azenta (AZTA) | United States | $1.410B | 61.54 |
| Phreesia (PHR) | United States | $1.387B | 0.00 |
| Schrodinger (SDGR) | United States | $1.323B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.286B | 0.00 |
| Claritev (CTEV) | United States | $0.966B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.899B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Talkspace (TALK) | United States | $0.562B | 113.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Evolent Health (EVH) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.454B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.369B | 0.00 |
| Carlsmed (CARL) | United States | $0.328B | 0.00 |
| TruBridge (TBRG) | United States | $0.303B | 13.93 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.292B | 0.00 |
| CapsoVision (CV) | United States | $0.259B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.243B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.201B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.195B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.175B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.174B | 0.00 |
| CareCloud (CCLD) | United States | $0.136B | 7.45 |
| EUDA Health Holdings (EUDA) | Singapore | $0.110B | 0.00 |
| Outset Medical (OM) | United States | $0.101B | 0.00 |
| Pulmonx (LUNG) | United States | $0.080B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.076B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.055B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.038B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.028B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.021B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.015B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Movano (MOVE) | United States | $0.010B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |